Literature DB >> 11451692

Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi.

D Nadjar1, R Labia, C Cerceau, C Bizet, A Philippon, G Arlet.   

Abstract

Ochrobactrum anthropi, formerly known as CDC group Vd, is an oxidase-producing, gram-negative, obligately aerobic, non-lactose-fermenting bacillus of low virulence that occasionally causes human infections. It is highly resistant to all beta-lactams except imipenem. A clinical isolate, SLO74, and six reference strains were tested. MICs of penicillins, aztreonam, and most cephalosporins tested, including cefotaxime and ceftazidime, were >128 microg/ml and of cefepime were 64 to >128 microg/ml. Clavulanic acid was ineffective and tazobactam had a weak effect in association with piperacillin. Two genes, ampR and ampC, were cloned by inserting restriction fragments of genomic DNA from the clinical strain O. anthropi SLO74 into pBK-CMV to give the recombinant plasmid pBK-OA1. The pattern of resistance to beta-lactams of this clone was similar to that of the parental strain, except for its resistance to cefepime (MIC, 0.5 ,micro/ml). The deduced amino acid sequence of the AmpC beta-lactamase (pI, 8.9) was only 41 to 52% identical to the sequence of other chromosomally encoded and plasmid-encoded class C beta-lactamases. The kinetic properties of this beta-lactamase were typical for this class of beta-lactamases. Upstream from the ampC gene, the ampR gene encodes a protein with a sequence that is 46 to 62% identical to those of other AmpR proteins and with an amino-terminal DNA-binding domain typical of transcriptional activators of the Lys-R family. The deduced amino acid sequences of the ampC genes of the six reference strains were 96 to 99% identical to the sequence of the clinical strain. The beta-lactamase characterized from strain SLO74 was named OCH-1 (gene, bla(OCH-I)).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451692      PMCID: PMC90649          DOI: 10.1128/AAC.45.8.2324-2330.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Ochrobactrum anthropi as an agent of nosocomial septicemia in the setting of AIDS.

Authors:  R Manfredi; A Nanetti; M Ferri; L Calza; M Tadolini; F Chiodo
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

Review 2.  The beta-lactamase cycle: a tale of selective pressure and bacterial ingenuity.

Authors:  A Matagne; A Dubus; M Galleni; J M Frère
Journal:  Nat Prod Rep       Date:  1999-02       Impact factor: 13.423

3.  Intravenous line infection due to Ochrobactrum anthropi (CDC Group Vd) in a normal host.

Authors:  M V Gill; H Ly; M Mueenuddin; P E Schoch; B A Cunha
Journal:  Heart Lung       Date:  1997 Jul-Aug       Impact factor: 2.210

4.  Sequences of homologous beta-lactamases from clinical isolates of Serratia marcescens with different substrate specificities.

Authors:  N Matsumura; S Minami; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Ochrobactrum anthropi infection of retained pacemaker leads.

Authors:  K C Earhart; K Boyce; W D Bone; M R Wallace
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

Review 6.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child.

Authors:  M Haditsch; L Binder; G Tschurtschenthaler; R Watschinger; G Zauner; H Mittermayer
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

8.  Cloning and nucleotide sequence of the gene coding for the major 25-kilodalton outer membrane protein of Brucella abortus.

Authors:  P de Wergifosse; P Lintermans; J N Limet; A Cloeckaert
Journal:  J Bacteriol       Date:  1995-04       Impact factor: 3.490

9.  Sequence analysis of two chromosomally mediated inducible beta-lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinase.

Authors:  T R Walsh; L Hall; A P MacGowan; P M Bennett
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

Review 10.  The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia.

Authors:  R C Spencer
Journal:  J Hosp Infect       Date:  1995-06       Impact factor: 3.926

View more
  20 in total

1.  Molecular and biochemical characterization of a novel class A beta-lactamase (HER-1) from Escherichia hermannii.

Authors:  Anne Beauchef-Havard; Guillaume Arlet; Valerie Gautier; Roger Labia; Patrick Grimont; Alain Philippon
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 2.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  Septic shock caused by Ochrobactrum anthropi in an otherwise healthy host.

Authors:  Adrien Kettaneh; François-Xavier Weill; Isabelle Poilane; Olivier Fain; Michel Thomas; Jean-Louis Herrmann; Laurent Hocqueloux
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Cloning and characterization of a chromosomal class C beta-lactamase and its regulatory gene in Laribacter hongkongensis.

Authors:  Susanna K P Lau; Pak-Leung Ho; Maria W S Li; Hoi-wah Tsoi; Raymond W H Yung; Patrick C Y Woo; Kwok-yung Yuen
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Multilocus sequence typing supports the hypothesis that Ochrobactrum anthropi displays a human-associated subpopulation.

Authors:  Sara Romano; Fabien Aujoulat; Estelle Jumas-Bilak; Agnès Masnou; Jean-Luc Jeannot; Enevold Falsen; Hélène Marchandin; Corinne Teyssier
Journal:  BMC Microbiol       Date:  2009-12-18       Impact factor: 3.605

Review 6.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

7.  Clinical characteristics of Ochrobactrum anthropi bacteremia.

Authors:  Hideharu Hagiya; Kouhei Ohnishi; Miyako Maki; Naoto Watanabe; Tomoko Murase
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

Review 8.  Beta-lactam antibiotics: from antibiosis to resistance and bacteriology.

Authors:  Kok-Fai Kong; Lisa Schneper; Kalai Mathee
Journal:  APMIS       Date:  2010-01       Impact factor: 3.205

9.  Draft genome of Ochrobactrum intermedium strain M86 isolated from non-ulcer dyspeptic individual from India.

Authors:  Girish Kulkarni; Dhiraj Dhotre; Mahesh Dharne; Sudarshan Shetty; Somak Chowdhury; Vatsala Misra; Sriprakash Misra; Milind Patole; Yogesh Shouche
Journal:  Gut Pathog       Date:  2013-04-04       Impact factor: 4.181

10.  The differential interaction of Brucella and ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens.

Authors:  Elías Barquero-Calvo; Raquel Conde-Alvarez; Carlos Chacón-Díaz; Lucía Quesada-Lobo; Anna Martirosyan; Caterina Guzmán-Verri; Maite Iriarte; Mateja Mancek-Keber; Roman Jerala; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno; Esteban Chaves-Olarte
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.